Created at 6:36 a.m. Aug, 25, 2026
Author: obriene12345
Related Note: 1474651327123 2
Rationale for change

Omalizumab should also be included in this list because it is an anti-IgE monoclonal antibody used to treat allergic asthma. It binds to free IgE, preventing IgE from binding to FcεRI receptors on mast cells and basophils and thereby decreasing the downstream release of inflammatory mediators.
Source: AMBOSS - https://next.amboss.com/us/article/Ph0WVf?q=what+drug+classes+treat+asthma+by+blocking+inflammation

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Empty field
Additional Resources
Empty field
One by one
Empty field
#AK_Other::AnKing_Image::Aiman::Arachidonic_Acid_Pathway #AK_Step1_v12::#Physeo::09_Pharm::08_Respiratory::06_Asthma_Treatment #AK_Step1_v12::#AMBOSS::-MaDrO #AK_Step1_v12::#B&B::20_Pulm::02_Obstructive_and_Restrictive_Diseases::05_Treatment_of_COPD_and_Asthma #AK_Step1_v12::#Physeo::09_Pharm::08_Respiratory::08_Anti-IL-5_Monoclonal_Therapy #PANCE::EOR::Family_med #AK_Step1_v12::#Physeo::^physeo_image_update #PANCE::PULM::obstructive_pulmonary_diseases #AK_Step1_v12::#FirstAid::16_Respiratory::05_Pharm::05_Asthma_drugs #AK_Step1_v12::#UWorld::Step::6508 #AK_Step1_v12::#B&B::20_Pulm::02_Obstructive_and_Restrictive_Diseases::05_Treatment_of_COPD_and_Asthma::Extra #AK_Step2_v12::#B&B::14_Pulmonary_Critical_Care::01_Pulmonary_Disease::02_Asthma::Extra #AK_Step2_v12::#Bootcamp::Medicine::02_Pulmonary_and_Critical_Care::01_Obstructive_Lung_Diseases::04_Chronic_Asthma_Management #AK_Step1_v12::#NinjaNerd::15_Respiratory::03_Pathology::09_Asthma #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::01_Autoimmune_disease_therapy::*Benralizumab #AK_Step1_v12::#OME::PreClinical::General_Physiology::Smooth_Muscle #AK_Other::AnKing_Image::!Subjects::Biochemistry::Arachidonic_Acid_Pathway #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::01_Autoimmune_disease_therapy::*Mepolizumab #AK_Step2_v12::#SketchyIM::03_Pulmonology::02_Obstructive_Pulmonary_Diseases::02_Chronic_Asthma_Management #PANCE::EOR::PEDS #AK_Step1_v12::^Systems::Respiratory::Pharmacology #AK_Step1_v12::#UWorld::#UWSA1 #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Textbooks::#Robbins::15_The_Lung #AK_Step1_v12::#SketchyPharm::04_Smooth_Muscle::02_Allergy_&_Pulmonary::02_Asthma_therapy #AK_Step1_v12::#Textbooks::#Abbas_Immunology::11_Hypersensitivity #AK_Other::Only_Step_1 #AK_Step2_v12::!Shelf::EM #AK_Step1_v12::#Bootcamp::Pulmonology::05_Obstructive_Lung_Disease::03_Asthma_Treatments #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::01_Autoimmune_disease_therapy::*Reslizumab #AK_Step2_v12::#FirstAid::14_Pulm::01_Obstructive_Lung_Disease::02_Asthma::Extra